PMA modulates ATP-sensitive K+ channels in insulin-secreting cells, causing both activation and inhibition likely through protein kinase modulation.
PMA effects on KATP channels warrant no clinical action; leaves open PKC's role in beta-cell excitability pending human validation.
The actions of 4 beta-phorbol 12-myristate 13-acetate (PMA; 10-100 nM) on the ATP-sensitive K+ channel have been studied in the RINm5F insulin-secreting cell line. These experiments were carried out using the inside-out patch and open-cell recording configurations of the patch-clamp technique. In the presence of intracellular ATP and ADP, PMA was found to have complex effects. Over short periods of time, i.e., less than 5 min, PMA promoted channel inhibition. However, in the sustained presence of the phorbol ester, this inhibition was only transient and was followed by a period of recovery and then stimulation of the channels. There were no effects of PMA on ATP-sensitive K+ (K+ATP) channels in the absence of intracellular ATP/ADP and in patches of membrane excised from cells that had been pretreated overnight with 1 microM PMA to downregulate endogenous C-kinase. The inactive phorbol ester 4 alpha-phorbol 12,13-didecanoate (10 nM-1 microM) was also found to have no actions on ATP-sensitive K+ channels. Overall, these data may suggest that through the modulation of protein kinase(s) associated with K+ATP channels, PMA is capable of causing both activation and inhibition of K+ channels in RINm5F cells.
No takes yet. Share an insight, caveat, or question.
M. J. Dunne (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: